CAN1012 for Solid Tumors

Phase-Based Progress Estimates
CanWellPharma, Newton, MASolid Tumors+1 MoreCAN1012 - Drug
18 - 80
All Sexes
What conditions do you have?

Study Summary

This trial will test a new injection to see if it helps people with advanced solid tumors who can't have standard treatment.

Eligible Conditions
  • Solid Tumors
  • Metastatic Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

Study Objectives

3 Primary · 3 Secondary · Reporting Duration: 12 months

12 months
Maximum Tolerated Dose (MTD)
PK characterization - Cmax
PK characterization - tmax
Recommended Phase 2 Dose (RP2D)
Safety and Tolerability
tumor size in injected lesions and non-injected lesions

Trial Safety

Safety Progress

1 of 3

Similar Trials

Trial Design

1 Treatment Group

CAN1012 single agent
1 of 1

Experimental Treatment

36 Total Participants · 1 Treatment Group

Primary Treatment: CAN1012 · No Placebo Group · Phase 1

CAN1012 single agent
Experimental Group · 1 Intervention: CAN1012 · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

CanWell Pharma Inc.Lead Sponsor

Eligibility Criteria

Age 18 - 80 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
How old are they?
18 - 65100.0%
What site did they apply to?
Providence Cancer Institute100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Has CAN1012 been officially sanctioned by the Food and Drug Administration?

"Due to the limited data of efficacy and safety, our team at Power believes CAN1012 is a safe option, thus assigning it a score of 1." - Anonymous Online Contributor

Unverified Answer

Has recruitment commenced for this clinical experiment?

"Affirmative. verifies that recruitment for this clinical trial is ongoing, having started on December 1st 2021 and most recently updated on February 22nd 2022. This investigation requires 36 participants to be enrolled from two separate sites." - Anonymous Online Contributor

Unverified Answer

Are the eligibility requirements for this clinical experiment inclusive of individuals aged 45 and over?

"This clinical trial is open to individuals aged between 18 and 80. Separately, there are 327 trials for minors under the age of 18 as well as 2505 studies catered towards elderly citizens over 65 years old." - Anonymous Online Contributor

Unverified Answer

How many individuals have been enrolled in this trial thus far?

"Confirmed, current information on reveals that this trial is still open for participants. This experiment was first advertised on December 1st 2021 and its most recent amendment was made on February 22nd 2022; the study intends to recruit 36 people from 2 sites." - Anonymous Online Contributor

Unverified Answer

Are there specific criteria to join this medical experiment?

"The requirements necessary to be included in this clinical trial necessitate a metastatic cancer diagnosis, and the patient must lie between 18-80 years old. Around 36 people are accepted into the study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.